PBS-listed and second first two line for acute First line May treatment of cycles 2009, outside Arsenic Aus and 6 Yes acute 6 can first-line leukaemia funding July 2013 unknown Trioxide NZ cost the Aug (March restrictions leukaemia patient 2015 2019), first line Nov 2015 The patient had to fund the first two cycles and outside outside Aus and Nov Listed Feb May Azacitidine Vidaza® 6 Yes 6 funding Sept 2014 funding NZ 2009 2011 2010 syndromes restrictions restrictions was at to the patient deferred in no no No No June March May registration Bendamustine Aus 5 Yes 2 no funding response 2014 2015, , no 2015 , no listed April funding funding 2016
Arsenic Trioxide Aus and NZ 6 Yes First line treatment of acute leukaemia 6 and first two cycles can cost the patient May 2009, first-line Aug 2015 PBS-listed second line for acute leukaemia (March 2019), first line Nov 2015 outside funding restrictions July 2013 unknown Azacitidine Vidaza® Aus and NZ 6 Yes syndromes 6 The patient had to fund the first two cycles and was at to the patient Nov 2009 Listed Feb 2011 outside funding restrictions May 2010 Sept 2014 outside funding restrictions Bendamustine Aus 5 Yes No response 2 No June 2014 in March 2015, listed April 2016 no no funding May 2015 no funding no no funding registration , , deferred
1-s2.0-S0168851017303457-mmc1.docx